We are live on ! Find out more
AR

Advisory Research Portfolio holdings

AUM $1B
1-Year Est. Return 50.12%
This Fund
S&P 500
This Quarter Est. Return
+9.43%
1 Year Est. Return
+50.12%
3 Year Est. Return
+144.24%
5 Year Est. Return
+295.18%
10 Year Est. Return
+886.87%
AUM
$1.25B
AUM Growth
-$22.5M
Cap. Flow
-$64.1M
Cap. Flow %
-5.13%
Top 10 Hldgs %
36.19%
Holding
463
New
112
Increased
98
Reduced
115
Closed
63

Top Buys

Rank Stock Value
1
OVV icon
Ovintiv
OVV
+$27.3M
2
AR icon
Antero Resources
AR
+$14.4M
3
HD icon
Home Depot
HD
+$9.11M
4
FOXA icon
Fox Class A
FOXA
+$8.62M
5
DAC icon
Danaos Corp
DAC
+$5.53M

Top Sells

Rank Stock Value
1
EQT icon
EQT Corp
EQT
+$59.4M
2
CTRA
Coterra Energy
CTRA
+$20.4M
3
DVN icon
Devon Energy
DVN
+$19.7M
4
ING icon
ING
ING
+$19M
5
STLA icon
Stellantis
STLA
+$12.4M

Sector Composition

Rank Sector Weight
1 Energy 33.98%
2 Technology 11.6%
3 Healthcare 11.04%
4 Industrials 10.23%
5 Consumer Discretionary 9.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OCSL icon
151
Oaktree Specialty Lending
OCSL
$1.15B
$1.41M 0.11%
63,960
-1,787
-3% -$40K
TJX icon
152
TJX Companies
TJX
$170B
$1.38M 0.11%
22,690
-5,480
-19% -$367K
CNNE icon
153
Cannae Holdings
CNNE
$675M
$1.34M 0.11%
55,973
-52,606
-48% -$1.48M
LGVC
154
DELISTED
LAMF Global Ventures Corp. I Class A Ordinary Shares
LGVC
$1.34M 0.11%
+134,850
New +$1.33M
AMBP icon
155
Ardagh Metal Packaging
AMBP
$3.02B
$1.34M 0.11%
+164,545
New +$1.42M
BCRX icon
156
BioCryst Pharmaceuticals
BCRX
$2.51B
$1.31M 0.1%
+80,482
New +$1.29M
VO icon
157
Vanguard Morningstar Mid-Cap ETF
VO
$111B
$1.31M 0.1%
22,020
FSS icon
158
Federal Signal
FSS
$7.51B
$1.28M 0.1%
37,935
+7,803
+26% +$291K
SHCO
159
DELISTED
Soho House & Co
SHCO
$1.28M 0.1%
165,026
+51,637
+46% +$455K
MAIN icon
160
Main Street Capital
MAIN
$5.47B
$1.28M 0.1%
30,001
-900
-3% -$38.5K
YTPG
161
DELISTED
TPG Pace Beneficial II Corp.
YTPG
$1.26M 0.1%
128,238
DOL icon
162
WisdomTree True Developed International Fund
DOL
$848M
$1.26M 0.1%
25,850
CUE icon
163
Cue Biopharma
CUE
$128M
$1.25M 0.1%
8,574
TMO icon
164
Thermo Fisher Scientific
TMO
$223B
$1.25M 0.1%
2,116
-9
-0.4% -$5.17K
KRYS icon
165
Krystal Biotech
KRYS
$9.72B
$1.25M 0.1%
18,731
+12,392
+195% +$773K
BRD
166
DELISTED
Beard Energy Transition Acquisition Corp.
BRD
$1.22M 0.1%
+123,250
New +$1.22M
JLL icon
167
Jones Lang LaSalle
JLL
$17B
$1.21M 0.1%
5,058
+1,100
+28% +$268K
THRM icon
168
Gentherm
THRM
$1.27B
$1.17M 0.09%
16,019
-12,707
-44% -$1.06M
BX icon
169
Blackstone
BX
$112B
$1.15M 0.09%
9,050
FNF icon
170
Fidelity National Financial
FNF
$12.8B
$1.13M 0.09%
24,113
-357
-1% -$17.1K
NE icon
171
Noble Corp
NE
$7.07B
$1.13M 0.09%
+32,298
New +$910K
ARCO icon
172
Arcos Dorados Holdings
ARCO
$1.71B
$1.1M 0.09%
+135,973
New +$938K
HLMN icon
173
Hillman Solutions
HLMN
$1.73B
$1.1M 0.09%
92,940
-129,940
-58% -$1.28M
BRSL
174
Brightstar Lottery PLC
BRSL
$2.15B
$1.09M 0.09%
44,090
-43,658
-50% -$1.17M
TGH
175
DELISTED
Textainer Group Holdings limited
TGH
$1.08M 0.09%
28,473
-14,341
-33% -$542K

Similar funds

Advisory Research's Q1 2022 Portfolio in Review

As of Q1 2022, Advisory Research held 463 positions worth $1.25B, down 1.8% from $1.27B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Advisory Research withdrew a net $64.1M in Q1 2022, closing 63 positions and reducing 115 holdings. Its most notable exit was EQT Corp, an estimated $59.4M position sold in full.

By sector, the portfolio is most concentrated in Energy at 34% of assets, up from 31% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Advisory Research opened a new position in Ovintiv worth $34.2M.

  • Advisory Research's largest Q1 2022 buy was Ovintiv: 633,386 shares worth $34.2M.
  • Advisory Research added most to Antero Resources in Q1 2022, an estimated $14.4M increase.
  • Advisory Research's biggest Q1 2022 reduction was Coterra Energy, cutting an estimated $20.4M.
  • Advisory Research fully exited EQT Corp in Q1 2022, selling an estimated $59.4M.
  • Advisory Research's ten largest holdings make up 36% of its $1.25B portfolio in Q1 2022.
  • Advisory Research opened 112 new positions and closed 63 in Q1 2022.
  • Advisory Research's portfolio value fell 1.8% quarter-over-quarter to $1.25B.

Based on Advisory Research's 13F filing for Q1 2022, filed 16 May 2022.